LOXL2 and renal cell carcinoma: In renal cell carcinoma (RCC), miR-26a/b overexpression exhibits inhibitory efficacy on cancer cell proliferation, migration, and invasion through the direct binding of 3′UTR of LOXL2 mRNA [65].